Notice2023-14697
Reorganization of the Strategic Business Initiatives Unit
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 12, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
CDC has modified its structure. This notice announces the reorganization of the Strategic Business Initiatives Unit (SBI). SBI converted from an activity within the Office of the Director of the Office of the Chief Operating Officer to a stand-alone business service office known as the Office of Strategic Business Initiatives.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 132 (Wednesday, July 12, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 132 (Wednesday, July 12, 2023)]
[Notices]
[Pages 44304-44306]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-14697]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Reorganization of the Strategic Business Initiatives Unit
AGENCY: Centers for Disease Control and Prevention (CDC), the
Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: CDC has modified its structure. This notice announces the
reorganization of the Strategic Business Initiatives Unit (SBI). SBI
converted from an activity within the Office of the Director of the
Office of the Chief Operating Officer to a stand-alone business service
office known as the Office of Strategic Business Initiatives.
DATES: This reorganization was approved by the Director of CDC on June
28, 2023.
[[Page 44305]]
FOR FURTHER INFORMATION CONTACT: Kimberly Thurmond, Office of the Chief
Operating Officer, Office of the Director, Centers for Disease Control
and Prevention, 1600 Clifton Road NE, MS TW-2, Atlanta, GA 30329.
Telephone 770-488-4401; Email: <a href="/cdn-cgi/l/email-protection#e89a8d879a8f9ba88b8c8bc68f879e"><span class="__cf_email__" data-cfemail="4e3c2b213c293d0e2d2a2d60292138">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Part C (Centers for Disease Control and
Prevention) of the Statement of Organization, Functions, and
Delegations of Authority of the Department of Health and Human Services
(45 FR 67772-76, dated October 14, 1980, and corrected at 45 FR 69296,
October 20, 1980, as amended most recently at 88 FR 9290-9291, dated
February 13, 2023) is amended to reflect the reorganization of the
Strategic Business Initiatives Unit within the Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
Specifically, the changes are as follows:
I. Under Part C, Section C-B, Organization and Functions, after the
Office of Safety, Security and Asset Management (CAJS) insert the
following:
<bullet> Strategic Business Initiatives (CAJT)
<bullet> Office of the Director (CAJT1)
<bullet> Management Operations Activity (CAJT12)
<bullet> Office of Business Integrity and Strategic Management (CAJTB)
<bullet> Office of the Federal Advisory Committee Act Program (CAJTC)
<bullet> Office of Management Analysis (CAJTD)
<bullet> Office of Transformation and Change Management (CAJTE)
II. Under Part C, Section C-B, Organization and Functions, retitle
the following organizational units:
<bullet> Strategic Business Initiatives (CAJT) to the Office of
Strategic Business Initiatives (CAJT)
III. Under Part C, Section C-B, Organization and Functions, add the
following functional statements:
Strategic Business Initiatives (CAJT). (1) serves as the lead
organizational entity delivering risk management training and support
across CDC, providing Federal Advisory Committee Act program
management, including assessments of applicability and guidance to all
committees, boards and other groups established by law; (2) strengthens
CDC's administrative guidance and change management through agency-wide
conference, gift, policy, delegations of authority, organization and
functions, and records management; (3) establishes a capability to
deliver transformation and change management to the Office of the Chief
Operating Officer (OCOO), the CDC and the Agency for Toxic Substances;
and (4) serves as liaison to the HHS Office of Inspector General (OIG)
on fraud, waste, and abuse allegations and fact finding.
Office of the Director (CAJT1). (1) directs, manages, coordinates
and evaluates the programs and activities of the Office of Strategic
Business Initiatives (SBI) I; (2) develops goals and objectives, and
provides leadership, policy formulation, and guidance in program
planning and development; (3) provides advice and counsel to the CDC
Immediate Office of the Director (IOD), the COO, and other senior IOD
and Centers, Institute, and Offices officials on all SBI programs and
activities; (4) provides quality assurance and continuous improvement
by establishing a framework for process improvement associated with all
SBI functions; (5) conducts quality improvement audits on all SBI
program areas of responsibility; (6) provides project management
support to SBI; (7) develops and communicates vision/mission, strategic
plans and goals/priorities for SBI and in alignment with OCOO; (8)
prepares special reports and studies, as required, in collaboration
with and support of SBI; and (9) serves as coordinator of continuity of
operations activities for SBI.
Management Operations Activity (CAJT12). (1) provides overall
budgetary, employee relations, human capital management, logistics and
administrative support; (2) collaborates and maintains liaison with
management officials to monitor and address priority issues of concern
to CDC leadership; (3) provides direction, strategy, analysis, and
operational support in all aspects of human capital management,
including workforce and career development and human resources
operations; (4) manages internal operational budget processes,
including planning, execution, and monitoring; (5) manages internal
acquisition processes; (6) serves as point of contact on all matters
concerning facilities management, property management, equipment,
travel, and space utilization and improvements; (7) coordinates SBI
requirements relating to contracts, grants, cooperative agreements, and
reimbursable agreements; (8) develops and implements administrative
policies, procedures, and operations, as appropriate, for SBI; and (9)
maintains liaison with related CDC components and other officials.
Office of Business Integrity and Strategic Management (CAJTB). (1)
provides fiscal advisory services; (2) researches and analyzes fiscal
issues and recommends solutions to address appropriations law matters
(i.e., clearance for roller bags, sit-stand workstations; food
purchases, etc.); (3) evaluates and conducts agency-wide enterprise
risk monitoring and management training and support, assisting programs
with assessments, building the agency risk profile, and conducting
special studies; (4) conducts special reviews and appraises the
adequacy and effectiveness of agency-wide practices and operations; (5)
coordinates responses to the OIG hotline and other agency special
reviews; (6) serves as the representative for the CDC Gift Review
Panel; and (7) oversees the management and implementation of the CDC
Conference Management Approval System to ensure agency fiscal and risk
management in association with conferences, collaborates with the
Office of Financial Resources travel office in this endeavor.
Office of the Federal Advisory Committee Act Program (CAJTC). (1)
provides Federal Advisory Committee Act (FACA) program oversight and
management, including assessments of applicability and guidance to all
committees, boards and other groups established by law, the President,
HHS or CDC officials; (2) provides FACA and ethics training for
committee members and CDC staff and FACA applicability training to CDC
programs and employees; (3) manage FACA ethics compliance, conflict of
interest mitigation, and financial disclosure forms for special
government employees serving on FACA committees and boards; (4) manages
and supports scheduling all advisory committees meetings, and
facilitates Federal Register notice postings; (5) oversees committee
operations to include nomination and charter packages, correspondence
procedures, and other documents related to committee members and
management; and (6) coordinates with HHS/CDC officials on FACA-related
matters to support compliance with FACA statutory, regulatory, and
policy requirements.
Office of Management Analysis (CAJTD). (1) consults with and
provides technical assistance to CDC programs, HHS, and interagency
partners, as appropriate, on operational policies; (2) develops,
coordinates, and formalizes CDC operational policies; (3) oversees and
manages the operational policy management process, requirements, and
database; (4) oversees the records management program; (5) serves as
the liaison to the National Archives and Records Administration (NARA);
(5) provides training and support to all programs on Federal records
management requirements and best
[[Page 44306]]
practices; (6) ensures compliance with NARA and Federal records
management requirements; and (7) interprets, analyzes, and makes
recommendations concerning delegations of program and administrative
authorities and develops appropriate delegating documents; (8) consults
with and provides technical assistance to CDC program officials seeking
to establish, modify, or abolish organizational structures and
functions; (9) manages the official standard administrative codes,
coordinating with HHS as appropriate; and (10) manages processes,
procedures, requirements, and databases for delegations of authority
and organizational structures and functions.
Office of Transformation and Change Management (CAJTE). (1)
develops, enables, and promotes an OCOO transformation framework and
learning organization; (2) develops and applies a structured approach
to change management to promote participation and buy-in; (3) creates
and maintains an internal collaboration site for programs to share and
build upon innovative ideas and operational improvements; (4)
establishes continuous process improvement ``community of practice'' to
validate and share best practices across OCOO and CDC; (5) promotes a
culture of continuous improvement through training, consultative
services, facilitation and technical support to build process
improvement expertise throughout OCOO; and (6) provide support to
programs in their project work driving innovation including
facilitating faster access to and dissemination of data and increased
effectiveness in services to support CDC's overall mission.
V. Under Part C, Section C-B, Organization and Functions, the
following organizational unit is deleted in its entirety:
Office of Strategic Business Initiatives (CAJ13) within the Office
of the Director, Office of the Chief Operating Officer.
Delegations of Authority
All delegations and redelegations of authority made to officials
and employees of affected organizational components will continue in
them or their successors pending further redelegation, provided they
are consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Robin D. Bailey, Jr.,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-14697 Filed 7-11-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 12, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.